Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul;3(3):142-149.
doi: 10.1016/j.ajur.2016.04.002. Epub 2016 May 13.

Stents for malignant ureteral obstruction

Affiliations
Review

Stents for malignant ureteral obstruction

Kristina Pavlovic et al. Asian J Urol. 2016 Jul.

Abstract

Malignant ureteral obstruction can result in renal dysfunction or urosepsis and can limit the physician's ability to treat the underlying cancer. There are multiple methods to deal with ureteral obstruction including regular polymeric double J stents (DJS), tandem DJS, nephrostomy tubes, and then more specialized products such as solid metal stents (e.g., Resonance Stent, Cook Medical) and polyurethane stents reinforced with nickel-titanium (e.g., UVENTA stents, TaeWoong Medical). In patients who require long-term stenting, a nephrostomy tube could be transformed subcutaneously into an extra-anatomic stent that is then inserted into the bladder subcutaneously. We outline the most recent developments published since 2012 and report on identifiable risk factors that predict for failure of urinary drainage. These failures are typically a sign of cancer progression and the natural history of the disease rather than the individual type of drainage device. Factors that were identified to predict drainage failure included low serum albumin, bilateral hydronephrosis, elevated C-reactive protein, and the presence of pleural effusion. Head-to-head studies show that metal stents are superior to polymeric DJS in terms of maintaining patency. Discussions with the patient should take into consideration the frequency that exchanges will be needed, the need for externalized hardware (with nephrostomy tubes), or severe urinary symptoms in the case of internal DJS. This review will highlight the current state of diversions in the setting of malignant ureteral obstruction.

Keywords: Hydronephrosis; Malignant ureteral obstruction; Ureteral stent.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Resonance metallic ureteral stent (permission for use granted by Cook Medical, Bloomington, IN, USA).
Figure 2
Figure 2
Memokath 051 ureteral stent (permission for use granted by PNN Medical, Glostrup, Denmark).
Figure 3
Figure 3
UVENTA ureteral stent (permission for use granted by TaeWoong Medical Co. Ltd., Gojeong-ro, Wolgot-myeon, Gimpo-si, Gyeonggi-do, South Korea).

References

    1. Yu S.H., Ryu J.G., Jeong S.H., Hwang E.C., Jang W.S., Hwang I.S. Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents. Korean J Urol. 2013;54:316–321. - PMC - PubMed
    1. Chung H.H., Kim M.D., Won J.Y., Won J.H., Cho S.B., Seo T.S. Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion. Cardiovasc Interv Radiol. 2013;37:463–470. - PubMed
    1. Chow P.M., Chiang I.N., Chen C.Y., Huang K.H., Hsu J.S., Wang S.M. Malignant ureteral obstruction: functional duration of metallic versus polymeric ureteral stents. PLoS One. 2015;10:e0135566. - PMC - PubMed
    1. Kulkarni R. Metallic stents in the management of ureteric strictures. Indian J Urol. 2014;30:65–72. - PMC - PubMed
    1. Kim K.S., Choi S., Choi Y.S., Bae W.J., Hong S.H., Lee J.Y. Comparison of efficacy and safety between a segmental thermo-expandable metal alloy spiral stent (Memokath 051) and a self-expandable covered metallic stent (UVENTA) in the management of ureteral obstructions. J Laparoendosc Adv Surg Tech A. 2014;24:550–555. - PubMed

LinkOut - more resources